See more : Rohto Pharmaceutical Co.,Ltd. (RPHCF) Income Statement Analysis – Financial Results
Complete financial analysis of CareRay Digital Medical Technology Co., Ltd. (688607.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of CareRay Digital Medical Technology Co., Ltd., a leading company in the Medical – Devices industry within the Healthcare sector.
- Bank of America Corporation (BML-PG) Income Statement Analysis – Financial Results
- Arbor Realty Trust, Inc. (ABR-PC) Income Statement Analysis – Financial Results
- Disruptive Acquisition Corporation I (DISAW) Income Statement Analysis – Financial Results
- Next Science Limited (NXS.AX) Income Statement Analysis – Financial Results
- Labrador Uranium Inc. (LURAF) Income Statement Analysis – Financial Results
CareRay Digital Medical Technology Co., Ltd. (688607.SS)
About CareRay Digital Medical Technology Co., Ltd.
CareRay Digital Medical Technology Co., Ltd. develops and produces digital X-ray flat panel detectors. The company offers wireless, wired, dynamic and breast flat panel, and industrial flat panel detectors, as well as accessories and tablet cases. Its products are used in medical, pet, security, and industrial imaging diagnostic products. The company was founded in 2007 and is headquartered in Suzhou, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 273.74M | 204.57M | 341.98M | 339.22M | 234.55M | 212.75M | 198.02M |
| Cost of Revenue | 170.94M | 129.71M | 184.33M | 191.99M | 131.05M | 114.70M | 114.50M |
| Gross Profit | 102.80M | 74.86M | 157.66M | 147.23M | 103.49M | 98.04M | 83.53M |
| Gross Profit Ratio | 37.55% | 36.59% | 46.10% | 43.40% | 44.12% | 46.08% | 42.18% |
| Research & Development | 42.77M | 44.52M | 32.37M | 26.07M | 19.31M | 13.18M | 12.88M |
| General & Administrative | 11.23M | 12.88M | 8.44M | 8.82M | 7.04M | 6.78M | 16.64M |
| Selling & Marketing | 11.94M | 22.18M | 21.38M | 18.74M | 20.32M | 21.27M | 17.13M |
| SG&A | 52.12M | 35.05M | 29.82M | 27.56M | 27.36M | 28.06M | 33.77M |
| Other Expenses | -5.87M | 15.94M | 14.12M | 10.53M | -351.12K | 625.91K | -570.35K |
| Operating Expenses | 88.97M | 95.52M | 76.30M | 64.15M | 46.32M | 46.37M | 48.49M |
| Cost & Expenses | 259.91M | 225.23M | 260.63M | 256.14M | 177.38M | 161.07M | 162.99M |
| Interest Income | 1.49M | 1.41M | 3.36M | 242.06K | 724.76K | 842.68K | 128.89K |
| Interest Expense | 658.82K | 370.57K | 208.65K | 344.20K | 443.22K | 567.10K | 1.47M |
| Depreciation & Amortization | 12.19M | 11.03M | 9.69M | 9.24M | 10.13M | 6.67M | 4.88M |
| EBITDA | 30.60M | 4.91M | 100.83M | 94.51M | 67.00M | 63.21M | 33.86M |
| EBITDA Ratio | 11.18% | 5.02% | 31.90% | 26.90% | 29.02% | 29.65% | 17.10% |
| Operating Income | 13.83M | 1.54M | 93.33M | 85.71M | 54.51M | 55.11M | 27.50M |
| Operating Income Ratio | 5.05% | 0.75% | 27.29% | 25.27% | 23.24% | 25.90% | 13.89% |
| Total Other Income/Expenses | 1.47M | -10.45M | 2.95M | 2.28M | 1.51M | 776.81K | -570.35K |
| Income Before Tax | 15.30M | -8.91M | 96.28M | 87.98M | 56.02M | 55.89M | 26.93M |
| Income Before Tax Ratio | 5.59% | -4.35% | 28.15% | 25.94% | 23.88% | 26.27% | 13.60% |
| Income Tax Expense | -105.77K | -3.24M | 11.23M | 12.87M | 7.84M | 6.60M | 5.34M |
| Net Income | 15.41M | -5.67M | 85.09M | 75.14M | 48.18M | 49.29M | 21.59M |
| Net Income Ratio | 5.63% | -2.77% | 24.88% | 22.15% | 20.54% | 23.17% | 10.90% |
| EPS | 0.17 | -0.06 | 0.97 | 0.85 | 0.55 | 0.75 | 0.36 |
| EPS Diluted | 0.17 | -0.06 | 0.97 | 0.85 | 0.55 | 0.75 | 0.36 |
| Weighted Avg Shares Out | 90.66M | 88.13M | 88.13M | 88.13M | 88.13M | 65.71M | 59.96M |
| Weighted Avg Shares Out (Dil) | 90.66M | 88.13M | 88.13M | 88.13M | 88.13M | 65.71M | 59.96M |
Source: https://incomestatements.info
Category: Stock Reports